The effects of the gonadotrophin releasing hormone analogue (goserelin) and prostaglandin E1 (misoprostol) on cervical resistance prior to transcervical resection of the endometrium
article
OA: closed
CC0
⤵ 4 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Goserelin and misoprostol were compared for their efficacy in reducing cervical resistance before transcervical endometrial resection.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
Cited by (4)
- Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding 2002
- Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding 2013
- A randomised trial comparing local <i>versus</i> general anaesthesia for microwave endometrial ablation 2003
- Overcoming the Challenging Cervix 2008
References (7)
- Use of danazol in hysteroscopic surgery for menorrhagia. via openalex
- W2002992487 via openalex
- W2054170830 via openalex
- W320140288 via openalex
- W2156400294 via openalex
- W4247494313 via openalex
- W2069233942 via openalex
Cited by (4)
- Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding 2013
- Overcoming the Challenging Cervix 2008
- A randomised trial comparing local <i>versus</i> general anaesthesia for microwave endometrial ablation 2003
- Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding 2002
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-08-25T06:41:39.333708+00:00
License: CC0
· commercial use OK